Dr Dan Hardy
Founder and CEO
PhD in physical chemistry, University of Bristol. Aerosol Society Doctoral Thesis Prize.
About Microsol
We are an aerosol science company in Bristol, combining single-particle measurement with simulation to support the development of orally inhaled and nasal drug products (OINDP).
Team
Chris Vernall
Commercial Lead
Experience in inhaled and nasal drug delivery from the laboratory to business development, at Nanopharm, Intertek Melbourn and Vectura.
Viktoriya Kaleva
R&D Engineer
Biomedical engineer leading development of our single-particle measurement instruments.
Enitan Ledger
EA and Operations Manager
Executive and research operations experience across the health and research sectors.
Board
Dr Catherine Prescott
Chair
Over thirty years in life science investment and company building. Founder of Biolatris.
Dr Natalie Pankova
Investor Director
Partner, Health and Life Sciences, at Zinc. PhD in medical science.
Pete Lockett
Investor Director
Founder of TP3 Global, a pharmaceutical cold chain company. Co-founder of Angel Investors Bristol.
Advisors
Prof. Jonathan Reid FRS
Scientific Advisor
University of Bristol
Fellow of the Royal Society. Director of the EPSRC Centre for Doctoral Training in Aerosol Science.
Prof. Darragh Murnane
Scientific Advisor
University of Hertfordshire
Led INFORM 2020, the EPSRC programme on computational formulation and inhaler design.
Dr Jim Walker
Technology Advisor
University of Bristol
Developed aerosol optical tweezers into a commercial instrument with Biral.
Dr Allen Haddrell
Scientific Advisor
University of Bristol
Twenty years in aerosol science. Developer of QELEBS, for studying airborne microorganisms.
Dr Peter Hirst
Commercial Advisor
Thirty years turning inhalation science into commercial strategy, deals and successful products.
Mark Sanders
Commercial Advisor
Inventor on eleven patents in respiratory formulation and devices.
Backed by
Collaborators
Member of
